GCP
LFMD icon

GSA Capital Partners’s LifeMD LFMD Stock Holding History

GSA Capital Partners’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-103,803
Closed -$565K – 1964
2025
Q1 		$565K Buy
103,803
+29,582
+40% +$168K 0.05% 711
2024
Q4 		$367K Buy
+74,221
New +$389K 0.03% 1096
2024
Q2 		– Sell
-21,902
Closed -$225K – 1865
2024
Q1 		$225K Buy
+21,902
New +$162K 0.02% 1356
2022
Q2 		– Sell
-146,955
Closed -$519K – 1618
2022
Q1 		$519K Buy
+146,955
New +$522K 0.07% 502

Other funds holding LFMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GSA Capital Partners's LFMD Position: Q2 2025 in Review

GSA Capital Partners sold out of LifeMD (LFMD) in Q2 2025, closing a stake of 103,803 shares — an estimated $565K sold.

GSA Capital Partners first reported a position in LFMD in Q1 2022 and held it in 4 quarters. The position peaked at $565K in Q1 2025. 128 funds tracked by Wall St. Rank hold LFMD as of Q2 2025.

  • GSA Capital Partners reported no remaining LifeMD position as of Q2 2025 after selling out during the quarter.
  • GSA Capital Partners sold 103,803 LifeMD shares in Q2 2025, an estimated $565K.
  • GSA Capital Partners first reported a position in LifeMD in Q1 2022 and held it in 4 quarters.
  • GSA Capital Partners's LifeMD position peaked at $565K in Q1 2025.
  • 128 funds tracked by Wall St. Rank held LifeMD as of Q2 2025.

Based on GSA Capital Partners's 13F filing for Q2 2025, filed 22 Jul 2025.